Portfolio Statistics

Assets

Total Fund AssetsAs of 04/30/2020 (updated monthly) $1,746.0 (M)
Net Assets - Class C As of 04/30/2020 (updated monthly) $32.4 (M)

Positions As of 04/30/2020

Equity VS. MSCI EAFE Index-NR

Fund Benchmark
Market CapitalizationAs of 04/30/2020 (updated monthly) $25,597.21(M) $50,727.16(M)
P/B RatioAs of 04/30/2020 (updated monthly) 4.39 1.39
P/E Ratio (12-mo Forward)As of 04/30/2020 (updated monthly) 31.30 16.09
Price to Cash FlowAs of 04/30/2020 (updated monthly) 22.05 7.73

Portfolio Details

Asset AllocationAs of 04/30/2020

[name] [value]
Equity 96.66%
Cash & Cash Equivalents 3.34%

Geographic BreakdownAs of 04/30/2020

No chart available for this data.
[name] [value]
United Kingdom 24.09%
Other 18.66%
Germany 12.71%
Netherlands 10.03%
Denmark 6.81%
Australia 6.33%
Japan 6.24%
Belgium 5.81%
Canada 5.68%
Italy 3.65%

sector breakdownAs of 04/30/2020

[name] [value]
Software & Services 21.57%
Pharmaceuticals, Biotechnology & Life Sciences 10.47%
Materials 9.84%
Health Care Equipment & Services 8.36%
Retailing 7.03%
Media & Entertainment 6.75%
Capital Goods 6.38%
Banks 6.04%
Diversified Financials 5.30%
Cash & Cash Equivalents 3.34%
Consumer Services 3.26%
Transportation 3.25%
Semiconductors & Semiconductor Equipment 3.23%
Commercial & Professional Services 3.00%
Automobiles & Components 2.18%

TOP TEN HOLDINGSAs of 04/30/2020

Issuer Country Industry % of total
HIKMA PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.76%
FINECOBANK BANCA FINECO SPA Italy Banks 3.65%
BOOHOO GROUP PLC United Kingdom Retailing 3.59%
SHOPIFY INC Canada Software & Services 3.55%
ADYEN NV Netherlands Software & Services 3.51%
DEUTSCHE BOERSE AG Germany Diversified Financials 3.51%
CYBERAGENT INC Japan Media & Entertainment 3.50%
MERCADOLIBRE INC Argentina Retailing 3.44%
UMICORE SA Belgium Materials 3.41%
CSL LTD Australia Pharmaceuticals, Biotechnology & Life Sciences 3.41%

Market Capitalization BreakdownAs of 04/30/2020

[name] [value]
<2.0 Billion 5.46%
2.0-5.0 Billion 14.85%
5.0-10.0 Billion 27.35%
10.0-25.0 Billion 24.72%
25.0-50.0 Billion 13.93%
>50.0 Billion 13.69%
N/A 0.00%